Brief: Acorda Therapeutics To Conduct 1-For-20 Reverse Stock Split
31/05/2023 21:55
May 31 (Reuters) - Acorda Therapeutics Inc ACOR.O :
* ACORDA THERAPEUTICS TO CONDUCT 1-FOR-20 REVERSE STOCK
SPLIT
* ACORDA THERAPEUTICS INC - REVERSE STOCK SPLIT WILL BECOME
EFFECTIVE AT 4:01 P.M. EASTERN TIME, ON JUNE 2, 2023
* ACORDA THERAPEUTICS INC - REVERSE STOCK SPLIT IS BEING
EFFECTED
TO REGAIN COMPLIANCE
Source text for Eikon: ID:nBw7fwJ4ca
Further company coverage: ACOR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acorda Therapeutics
See all newsBrief: Acorda TherapeuticsCourt Held Hearing To Consider Approval Of Sale Of Substantially All Of Co's Assets To Merz Pharmaceuticals Under Asset Sale
Brief: Acorda Says Debtors Did Not Receive More Than One Qualified Bid Before Bid Deadline, In Connection With Chapter 11 Proceedings
Live Markets: Biotech companies in 'Darwinian' world as cash remains king
U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease (updated)
U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease